
Ischemic Injury
A Molecular Insight
- 564 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
About this book
The World Stroke Organization reports that "stroke has already reached epidemic proportions. Globally1 in 4 adults over the age of 25 will have a stroke in their lifetime. 12.2 million people worldwide will have their first stroke this year, and 6.5 million will die as a result." Ischemic strokes are the most common type of stroke, with about 87% of all strokes being ischemic strokes.
This new volume addresses this epidemic by presenting detailed studies on ischemic injury, with emphasis on the molecular-level mechanisms and the role of signaling pathways in the body, their structure, and their mechanism of action. The book focuses on molecular pharmacology plans and explains the new areas of research on the discovery of therapeutic molecules that can be used for combating this life-threatening disease. The authors discuss stroke occurrence at different stages of life as well as sex-based differences in its treatment. They cover aspects of the clinical treatment and diagnosis of patients with cardiovascular events, including in-depth information on the prevention, evaluation, therapy selection, result projection, and long-term course of the disease in affected patients. They also detail the involvement of platelets, neurotransmitters, renin-angiotensin-aldosterone system, and vitamin D in ischemic injury.
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- Cover Page
- Half Title Page
- Title Page
- Copyright Page
- About the Editors
- Contents
- Contributors
- Abbreviations
- Preface
- Chapter 1 Stroke Insight
- Chapter 2 Myocardial Ischemic-Reperfusion Injury
- Chapter 3 Preclinical and Clinical Aspects of I/R Injuries
- Chapter 4 Molecular Aspects of Ischemic Reperfusion Injury
- Chapter 5 Role of Mitochondria in Ischemic-Reperfusion Injury
- Chapter 6 Stroke and its Effects in Daily Life
- Chapter 7 Etiopathogenesis and Molecular Targets in Cerebral Ischemia: Current Understanding of Stroke and Therapeutic Approaches
- Chapter 8 Expatiating the Pivotal Role of Matrix Metalloproteinases and Blood-Brain Barrier Disruption in Ischemic Stroke: Molecular Insights and Therapeutic Targets
- Chapter 9 Acute Ischemic Stroke in COVID-19 Patients
- Chapter 10 Neurotransmission Imbalance: A Major Factor in the Worsening of Ischemic Injury
- Chapter 11 Role of the Renin-Angiotensin-Aldosterone System (RAAS) in Amelioration of Stroke Pathophysiology
- Chapter 12 Stroke and Diabetes in Vitamin D Deficiency: Prospects of Intertwined Pathobiologies
- Chapter 13 Remote Ischemic Postconditioning: An Overview
- Chapter 14 Sex-Based Differences in Acute Kidney Injury: Lessons from Renal Ischemia-Reperfusion Injury Model in Rodents
- Chapter 15 Critical Overview of Conditioning Techniques and Their Current Status in the Treatment of Myocardial Ischemia-Reperfusion Injury
- Chapter 16 Involvement of Platelets in Myocardial Ischemia and Reperfusion Injury
- Chapter 17 Recent Advancements in Strategies for the Treatment of Cerebral Ischemia
- Chapter 18 Recent Therapeutic Approaches Toward the Management of Ischemic Heart Disease
- Chapter 19 Nanotechnology-Assisted Treatment for Ischemic Heart Disease and Related Recent Patents
- Chapter 20 Major Risk Factors Involved in the Pathobiology of Ischemic Brain and Heart Disorders
- Chapter 21 Modulating Mitogen-Activated Protein Kinase (MAPK) Downstream Signaling Pathways in Cerebral Ischemic Hemorrhages
- Chapter 22 Implication of Mitogen-Activated Protein Kinase (MAPK) in Cerebral Stroke
- Chapter 23 Regulation of JNK Signaling Pathway in Ischemia/Reperfusion Injury
- Chapter 24 Role of Glycogen Synthase Kinase-3β (Gsk-3β) in Intracranial Hemorrhage
- Chapter 25 Role of GSK-3 Inhibition in Modulating the Pathology of Stroke
- Chapter 26 Regulation of Nrf-2 Signaling Pathway in Ischemia/Reperfusion Injury
- Chapter 27 Regulation of PI3K-Akt Signaling Pathway in Ischemia/Reperfusion Injury
- Chapter 28 COVID-19 and Ischemic Stroke: Advancements and Challenges
- Index